6.28

5.02% 0.30

Reshape Lifesciences Inc (RSLS)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$5.98

Offen:

$5.98

24-Stunden-Volumen:

59,267

Relative Volume:

0.09

Marktkapitalisierung:

$4.65M

Einnahmen:

$9.81M

Nettoeinkommen (Verlust:

$-26.16M

KGV:

-0.162

EPS:

-38.77

Netto-Cashflow:

$-17.45M

1W Leistung:

-5.71%

1M Leistung:

-30.82%

6M Leistung:

-95.21%

1J Leistung:

-97.46%

1-Tages-Spanne:

$5.8638

$6.80

1-Wochen-Bereich:

$5.6447

$6.80

52-Wochen-Spanne:

$5.53

$725.00

Reshape Lifesciences Inc Stock (RSLS) Company Profile

Firmenname

Reshape Lifesciences Inc

Sektor

Healthcare (1170)

Branche

Medical Devices (156)

Telefon

949-429-6680

Adresse

1001 CALLE AMANECER, SAN CLEMENTE

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

RSLS's Discussions on Twitter

Vergleichen Sie RSLS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RSLS Reshape Lifesciences Inc	6.28	3.00M	9.81M	-26.16M	-17.45M	-38.77
ABT Abbott Laboratories	134.80	231.82B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	106.04	152.18B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	394.21	145.57B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	86.44	107.07B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	78.00	43.22B	5.54B	4.18B	623.10M	7.00

Reshape Lifesciences Inc Aktie (RSLS) Neueste Nachrichten

May 15, 2025

ReShape Lifesciences Delays 10-Q Filing - TipRanks

May 15, 2025

May 12, 2025

Orla Mining, ReShape Lifesciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

May 12, 2025

May 11, 2025

Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - MSN

May 11, 2025

May 09, 2025

Reshape Lifesciences Inc Files For Mixed Shelf Offering Of Up To $50 MillionSEC Filing - marketscreener.com

May 09, 2025

ReShape Lifesciences Announces Reverse Stock Split - TipRanks

May 09, 2025

May 07, 2025

ReShape Lifesciences announces 1-for-25 reverse stock split By Investing.com - Investing.com Canada

May 07, 2025

ReShape Lifesciences (RSLS) Announces 1-for-25 Reverse Stock Split - GuruFocus

May 07, 2025

ReShape Lifesciences announces 1-for-25 reverse stock split - Investing.com Australia

May 07, 2025

ReShape Lifesciences Announces 1-for-25 Reverse Stock Split - The Manila Times

May 07, 2025

ReShape Lifesciences Inc. Announces 1-for-25 Reverse Stock Split Effective May 9, 2025 - Nasdaq

May 07, 2025

May 03, 2025

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The MergerALBT, NDOI, DNB, RSLS - The Malaysian Reserve

May 03, 2025

May 02, 2025

ReShape Lifesciences (RSLS) Secures Patent for Innovative Intrag - GuruFocus

May 02, 2025

ReShape Lifesciences (RSLS) Showcases Promising Diabetes Device at Neuromodulation Event | RSLS Stock News - GuruFocus

May 02, 2025

ReShape Lifesciences® Unveils Innovative Diabetes Neuromodulation Device Demonstrating Safe Glucose Modulation at Minnesota Neuromodulation Symposium - Nasdaq

May 02, 2025

ReShape Lifesciences® Presents Pre-clinical Data on Its - GlobeNewswire

May 02, 2025

Breakthrough Diabetes Treatment: New Neuromodulation Device Eliminates Need for Insulin Injections - Stock Titan

May 02, 2025

May 01, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – ALBT, NDOI, DNB, RSLS - GlobeNewswire Inc.

May 01, 2025

Apr 30, 2025

The Psychology of ReShape Lifesciences Inc Inc. (RSLS) Price Performance: Understanding Market Sentiment - investchronicle.com

Apr 30, 2025

There is no way ReShape Lifesciences Inc (RSLS) can keep these numbers up - Sete News

Apr 30, 2025

Apr 29, 2025

Market Resilience: ReShape Lifesciences Inc (RSLS) Finishes Weak at 0.36, Down -0.85 - DWinneX

Apr 29, 2025

Checking in on ReShape Lifesciences Inc (RSLS) after recent insiders movement - knoxdaily.com

Apr 29, 2025

Closing Figures Unveiled: ReShape Lifesciences Inc (RSLS) Drop -12.17, Closes at 0.39 - DWinneX

Apr 29, 2025

Apr 28, 2025

ReShape Lifesciences amends asset purchase terms with Ninjour By Investing.com - Investing.com Nigeria

Apr 28, 2025

ReShape Lifesciences secures patent for intragastric balloon By Investing.com - Investing.com Canada

Apr 28, 2025

ReShape Lifesciences amends asset purchase terms with Ninjour - Investing.com

Apr 28, 2025

ReShape Lifesciences (RSLS) Advances with New Patent for Intraga - GuruFocus

Apr 28, 2025

ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System - The Manila Times

Apr 28, 2025

Revolutionary Weight Loss Tech: ReShape's New Patent Protects Self-Deflating Gastric Balloon Innovation - Stock Titan

Apr 28, 2025